26 related articles for article (PubMed ID: 7784086)
1. Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase.
Mustelin T; Coggeshall KM; Altman A
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6302-6. PubMed ID: 2548204
[TBL] [Abstract][Full Text] [Related]
2. Synthetic fragments of the CD4 receptor cytoplasmic domain and large polycations alter the activities of the pp56lck tyrosine protein kinase.
Bramson HN; Casnellie JE; Nachod H; Regan LM; Sommers C
J Biol Chem; 1991 Aug; 266(24):16219-25. PubMed ID: 1908465
[TBL] [Abstract][Full Text] [Related]
3. Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck).
Marth JD; Cooper JA; King CS; Ziegler SF; Tinker DA; Overell RW; Krebs EG; Perlmutter RM
Mol Cell Biol; 1988 Feb; 8(2):540-50. PubMed ID: 3352600
[TBL] [Abstract][Full Text] [Related]
4. The conserved lysine of the catalytic domain of protein kinases is actively involved in the phosphotransfer reaction and not required for anchoring ATP.
Carrera AC; Alexandrov K; Roberts TM
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):442-6. PubMed ID: 8421674
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an active, non-myristylated, cytoplasmic form of the lymphoid protein tyrosine kinase pp56lck.
Carrera AC; Li P; Roberts TM
Int Immunol; 1991 Jul; 3(7):673-82. PubMed ID: 1911540
[TBL] [Abstract][Full Text] [Related]
6. Regulation of pp56lck during T-cell activation: functional implications for the src-like protein tyrosine kinases.
Marth JD; Lewis DB; Wilson CB; Gearn ME; Krebs EG; Perlmutter RM
EMBO J; 1987 Sep; 6(9):2727-34. PubMed ID: 3119327
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase.
Jimenez C; Jones DR; Rodríguez-Viciana P; Gonzalez-García A; Leonardo E; Wennström S; von Kobbe C; Toran JL; R-Borlado L; Calvo V; Copin SG; Albar JP; Gaspar ML; Diez E; Marcos MA; Downward J; Martinez-A C; Mérida I; Carrera AC
EMBO J; 1998 Feb; 17(3):743-53. PubMed ID: 9450999
[TBL] [Abstract][Full Text] [Related]
8. Lck unique domain influences Lck specificity and biological function.
Carrera AC; Paradis H; Borlado LR; Roberts TM; Martinez C
J Biol Chem; 1995 Feb; 270(7):3385-91. PubMed ID: 7531706
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase specific motif at subdomain VIII does not confer specificity for tyrosine.
Carrera AC; Borlado LR; Roberts TM; Martinez C
Biochem Biophys Res Commun; 1994 Dec; 205(2):1114-20. PubMed ID: 7528498
[TBL] [Abstract][Full Text] [Related]
10. The catalytic domain of pp56(lck), but not its regulatory domain, is sufficient for inducing IL-2 production.
Carrera AC; Calvo V; Borlado LR; Paradis H; Alemany S; Roberts TM; Martinez-A C
J Immunol; 1996 Nov; 157(9):3775-82. PubMed ID: 8892605
[TBL] [Abstract][Full Text] [Related]
11. IL-2 stimulation of T lymphocytes induces sequential activation of mitogen-activated protein kinases and phosphorylation of p56lck at serine-59.
Watts JD; Welham MJ; Kalt L; Schrader JW; Aebersold R
J Immunol; 1993 Dec; 151(12):6862-71. PubMed ID: 8258696
[TBL] [Abstract][Full Text] [Related]
12. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
13. Role of the autophosphorylation site on the biological function of pp56lck.
Carrera AC; Borlado LR; Gonzalez-Garcia A; Roberts TM; Martinez C
Oncogene; 1995 Jun; 10(12):2379-86. PubMed ID: 7784086
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
